What is the diagnosis for a patient with a tricuspid valve (TV) showing trivial regurgitation, normal structure, and a tricuspid regurgitation (TR) velocity of 1.2 meters per second (m/s)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The tricuspid valve function appears essentially normal with only physiologic (trivial) regurgitation, and no intervention is required based on the provided echocardiographic findings. The tricuspid valve assessment shows normal structure with trivial regurgitation and no stenosis. The inferior vena cava (IVC) caliber is 1.3 cm, which is within normal limits, suggesting normal right atrial pressure, as indicated by the measured right atrial pressure of 3 mmHg, which is also normal 1. The tricuspid regurgitation velocity is 1.2 m/s, indicating a low pressure gradient across the valve during regurgitation.

Key Findings

  • Normal tricuspid valve structure
  • Trivial regurgitation
  • No stenosis
  • Normal IVC caliber (1.3 cm)
  • Normal right atrial pressure (3 mmHg)
  • Low tricuspid regurgitation velocity (1.2 m/s)

According to the 2014 AHA/ACC guideline for the management of patients with valvular heart disease, these findings are consistent with Stage A, "At risk of TR" or possibly early Stage B, "Progressive TR", but given the trivial nature of the regurgitation and the absence of any significant hemodynamic alterations, the valve function is considered normal 1. The normal IVC size and low right atrial pressure indicate adequate right heart function without evidence of right-sided heart failure or pulmonary hypertension. The low TR velocity further confirms the absence of pulmonary hypertension, as elevated pulmonary artery pressures would typically result in higher TR velocities. Regular cardiac follow-up can continue as scheduled, but no specific treatment is needed for the tricuspid valve based on these echocardiographic findings.

From the Research

Tricuspid Valve Structure and Function

  • The tricuspid valve is a complex structure that plays a crucial role in maintaining normal cardiac function 2.
  • The valve is composed of three leaflets that work together to regulate blood flow between the right atrium and ventricle.
  • In the given scenario, the tricuspid valve structure is reported as normal, with no significant stenosis or regurgitation.

Tricuspid Regurgitation and Stenosis

  • Tricuspid regurgitation is a common valvular abnormality that can occur due to various factors, including annular dilatation, atrial fibrillation, or left-sided heart disease 2.
  • In the given scenario, trivial tricuspid regurgitation is reported, with a TR velocity of 1.2 m/s and a TR gradient of >50%.
  • Tricuspid stenosis is not reported in the given scenario.

Diagnostic Imaging and Assessment

  • Transthoracic echocardiography is the first-line imaging modality for assessing right-sided valve disease, including tricuspid valve abnormalities 2.
  • The principle objectives of echocardiographic assessment include determining the aetiology, mechanism, and severity of valvular dysfunction, as well as consequences on right heart remodelling and estimations of pulmonary artery pressure.
  • In the given scenario, the IVC calibre is reported as 1.3 cm, and the RVSP is not specified.

Clinical Relevance and Management

  • The management of tricuspid valve abnormalities depends on the severity of the condition, as well as the presence of symptoms and other comorbidities.
  • Clinical practice guidelines play a crucial role in informing management decisions, and clinicians must carefully evaluate the trustworthiness of the guideline development process and the applicability of the recommendations to their practice setting 3.
  • In the given scenario, the clinical relevance and management of the tricuspid valve abnormality are not explicitly stated, and further evaluation and assessment may be necessary to determine the optimal course of action.

Related Questions

What is the diagnosis for a patient with a tricuspid valve (TV) showing trivial regurgitation, normal structure, and a tricuspid regurgitation (TR) velocity of 1.2 meters per second (m/s)?
What is the recommended follow-up care at 36 weeks for a patient who had a follow-up at 4 days old?
What is the best course of action for an 82-year-old lady with generalized severe depression, adrenal insufficiency, on oral cortisone and Lustral (sertraline), who is bedridden, sleeps excessively, and has hyponatremia?
What is the best next step in managing a postpartum patient with fatigue, perineal discomfort, and bloody vaginal discharge, who is 8 hours status post uncomplicated vaginal delivery with a second-degree laceration repair and has a firm, nontender uterine fundus?
What is the best next step in evaluating a 1-hour-old boy with intermittent cyanosis during breastfeeding, normal pulse oximetry, and no murmurs, who was born at 40 weeks gestation via spontaneous vaginal delivery (SVD) with normal Apgar scores?
What are the cognitive effects of Dayvigo (Lemborexant) and Clonazepam on cognition?
What are the differences between Department of Defense (DOD) guidelines, National Institute for Health and Care Excellence (NICE) guidelines, and American Psychiatric Association (APA) guidelines for the treatment of bipolar disorder?
What is the best hospital in the Syracuse area for a 10-year-old girl with influenza (flu) and complications?
What are the implications of wearing contact lenses in a patient with bacterial conjunctivitis?
What is Barrett's (Barrett's esophagus) disease in layman's terms?
In patients with refractory shock to catecholamines (e.g. epinephrine, norepinephrine), what determines the choice between adding a second inotrope or using alternative medications such as milrinone, levosimendan, or terlipressin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.